Diamond Education Foundation The Shifting Migraine Paradigm 2024

• Target Audience: neurologists, headache specialists, primary care physicians
• Sample video: contact me for sample video
• Information:

This three-day conference, held in San Antonio, Texas, focused on the evolving landscape of headache medicine early in the year. The course addressed the “shifting paradigm” of migraine care, specifically re-evaluating long-standing beliefs about medication safety and efficacy. It offered a critical look at the comparative safety profiles of traditional therapies (like triptans) versus newer agents (CGRP inhibitors) and provided updates on integrative approaches, including the use of supplements and medical foods.

• What You Will Learn

Attendees were able to:

Re-evaluate the cardiovascular safety profile of triptans compared to CGRP monoclonal antibodies, challenging previous assumptions about risk.

Integrate medical foods and evidence-based supplements into standard migraine treatment protocols.

Update management strategies for complex headache disorders using the latest clinical data available at the start of 2024.

Discuss the practical application of new therapeutics in a smaller, focused setting designed for direct interaction with faculty.

Network with peers to share “in-the-trenches” strategies for managing insurance barriers and patient expectations.

• Event Details

Location: Plaza San Antonio Hotel & Spa, San Antonio, Texas

Organizer: Diamond Headache Clinic Research & Educational Foundation

• Who Should Attend

The course was designed for the interdisciplinary headache care team:

Neurologists

Primary Care Physicians (Family Practice, Internal Medicine)

Nurse Practitioners (NPs) and Physician Assistants (PAs)

Nurses

Pharmacists

• Why Attend

Intimate Venue: The Plaza San Antonio offered a setting conducive to networking and one-on-one discussions with key opinion leaders in headache medicine.

Integrative Focus: The inclusion of topics like “Supplements and Medical Foods” addressed the growing patient demand for holistic and non-pharmaceutical options alongside standard medical treatments.

• Topics:

When Dizzy is Actually a Migraine

Trigeminal Autonomic Cephalalgias (TACs) and Facial Neuralgias

Tension-Type and Cervicogenic Headache Disorders

Optimization of Diagnosis and Treatment

Migraine and Dementia – 2024 Updates

Intractable Headache & Difficult Management Issues

Rare Primary Headache Disorders – We are in the Weeds of the ICHD 3

Multidisciplinary Approach to Intractable Headache Patients – 2024 Updates

Post-Traumatic Headache – Concussion & Post Concussion in Children

Indomethacin Responsive Headache Syndromes – 2024 Updates

How to Deal with Special Patients – Pearls for Success – 2024 Updates

Migraine Management 2017 vs. 2024 – Patient Dialogue Today

CGRP & the New Treatment Paradigm

Spontaneous Intracranial Hypotension (SIH) – A Recent Case

Layering Therapies – What Do We Know

Disparities in Migraine Care – 2024 Updates

Diagnosis and Management – Pediatric Migraine

Headache/Migraine in Pregnancy & Lactation

Menstrual Migraine

Perimenopause, Menopause & Migraine

New Patient Appointments in The Headache Clinic – How to Begin

Migraine Stigma

Chronic Analgesics, Comorbid Pain Disorders, and Medication Overuse Headache

Thunderclap Headache

Management of the Difficult Cluster Headache Patients – 2024 Update

Neuroimaging of Secondary Headaches and Red Flags

Supplements and Medical Food for Headaches

Devices and Blocks for Headache

Inpatient Headache Treatment – 2024 Update

A Case-Based Approach to Understanding CSF Pressure Disorders

Unraveling the Connection Between Migraine and Autonomic Dysfunction

Finding Fistulas

Medication Overuse Headache – July 2025

PACAP and Amylin in Migraine

Unmasking the Myths of Idiopathic Intracranial Hypertension

Sinus Headache – A Case

Facial Neuralgias & Trigeminal Autonomic Cephalalgias